As of 2025-09-17, the Intrinsic Value of Kaleido Biosciences Inc (KLDO) is -30,714.95 USD. This KLDO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.29 USD, the upside of Kaleido Biosciences Inc is -10,591,462.00%.
Based on its market price of 0.29 USD and our intrinsic valuation, Kaleido Biosciences Inc (KLDO) is overvalued by 10,591,462.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -30,714.95 - -30,714.95 | -30,714.95 | -10,591,462.00% |
| P/E | (105,659.45) - (115,119.66) | (110,113.12) | -37970140.9% |
| DDM - Stable | (47.84) - (81.57) | (64.71) | -22412.2% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 0.00 |
| Beta | -1,254.48 |
| Outstanding shares (mil) | 0.01 |
| Enterprise Value (mil) | -16.78 |
| Market risk premium | 4.60% |
| Cost of Equity | 7,887.21% |
| Cost of Debt | 5.00% |
| WACC | 5.22% |